Our Team of Compassionate Use Experts

Early Access Care team members are dedicated to the unique needs of pre-approval access to investigational drug products. Our staff are multi-disciplinary with expertise in strategy, design, and operational implementation of global pre-approval access programs.

With extensive experience in compassionate use / expanded access, clinical R&D, and full development, Early Access Care understands what is needed to successfully develop drug products and will work collaboratively to develop and implement the right program to meet your company’s compassionate use / expanded access needs.

Anne B. Cropp Chief Scientific Officer
Sarah Alummootil Associate Director, Early Access Programs
William Leidt Director of Technology
John W. Cropp CEO and SVP of Technology
Annette Silvia Director, Early Access Programs
Karen Reilly Executive Director, Data Management and Solutions
Nancy J. Hayden Clinical Records Manager and Controlled Document Specialist
Johanna Hancock Director, Early Access Programs
Brittany Mickolichek Sr. Associate Director, Early Access Programs
Kim Thompson Associate Director, Early Access Programs
Natacha Noisette Associate Director, Early Access Programs
Gabriela A. Mateo Associate Director, Early Access Programs
Judy Schomer Early Access Operations Associate
Suzanne Noeding Clinical Records Manager and Controlled Document Specialist
Cecelia A. Cropp Expanded Access Assistant

Want to learn more about our Expanded Access Capabilities?